Evidence map›Paper›PMID 30315217›Full record

ArticleNature communications2018

Cramming versus threading of long amphiphilic oligomers into a polyaromatic capsule.

Masahiro Yamashina, Shunsuke Kusaba, Munetaka Akita, Takashi Kikuchi, Michito Yoshizawa

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Chiral PdAngewandte Chemie (International ed. in English) · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. An atropisomeric MChemical science · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Masahiro YamashinaLaboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, 4259 Nagatsuta, Midori-ku, Yokohama, 226-8503, Japan.
Shunsuke KusabaLaboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, 4259 Nagatsuta, Midori-ku, Yokohama, 226-8503, Japan.
Munetaka AkitaLaboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, 4259 Nagatsuta, Midori-ku, Yokohama, 226-8503, Japan.
Takashi KikuchiRigaku Corporation, 3-9-12 Matsubaracho, Akishima, Tokyo, 196-8666, Japan.
Michito YoshizawaLaboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, 4259 Nagatsuta, Midori-ku, Yokohama, 226-8503, Japan. yoshizawa.m.ac@m.titech.ac.jp.
Tokyo Institute of Technology · JPLife Science Institute · JPSeikagaku Corporation (Japan) · JP

Funding

Tokyo Institute of Technology (Tokyo Tech) Support for Tokyotech Advanced Researchers
6 · The paper itself

Abstract

Oligo(ethylene oxide)s are known as widely useable yet not very interactive amphiphilic compounds. Here we report that the long amphiphilic oligomers are bound by a polyaromatic capsule in two different manners, depending on the chain length. For instance, the shorter pentamer is crammed into the isolated cavity of the capsule, whereas the longer decamer is threaded into the capsule to form a 1:1 host-guest complex in a pseudo-rotaxane fashion. These unusual bindings occur instantly, spontaneously, and quantitatively even in water at room temperature, with relatively high binding constants (K

Identifiers

PMID30315217
PMCPMC6185989
OpenAlexW2896532086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.